brand names of glp 1 drugs GLP-1 Agonist I KFF's latest Health Tracking Poll
Description
Del Prato S, Kang J, Trautmann ME, Stewart J, Sorli CH, Derwahl M, et al
doi: 10.1089/dia.2011.0050 90 BushMAMatthewsJEDe BoeverEHDobbinsRLHodgeRJWalkerSEet al
Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis
Diabetes Care 2019;42:S90-S102
Evidence base : Semaglutide has been studied in large, randomized controlled trials involving tens of thousands of patients, with well-established safety and efficacy profiles
Sustained Impact Weight loss extended for most individuals, even months after discontinuing
